License

License Not Specified

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A 14-Month Open-Label Extension Phase of the Double-Blind Placebo-Controlled Dose-Escalation Parallel-Group Study of E2007 as an Adjunctive Therapy in Patients With Refractory Partial Seizures revised per Amendments 02 and 03

The primary objective for this study is to evaluate the safety of E2007 given as adjunctive long-term treatment in patients with refractory partial onset seizures with or without secondary generalization that completed the E2007-A001-206 or the E2007-G000-208 study

FieldValue
Modified
2019-12-23
Release Date
2019-05-14
Identifier
05075424-3ed5-4438-a524-1e18e457b463
License
License Not Specified
Public Access Level
Public